Showing 1 - 1 results of 1 for search 'R Vemu', query time: 0.02s Refine Results
  1. 1
    TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy

    TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy by KO McNerney, S Karageorgos, GM Ferry, AJ Wolpaw, C Burudpakdee, P Khurana, CN Toland, R Vemu, A Vu, MD Hogarty, H Bassiri

    Published 2022-12-01
    Get full text
    Article

Search Tools: